The hormone requiring the character of hormone-receptor-positive breast cancers for female hormones (i.e., estrogen and/or progesterone) [11] has brought up the idea of hormone therapies that include using hormone-receptor modulators of which tamoxifen (TMX) is the oldest one. The gene discussed is NR4A1; the disease is breast carcinoma.